This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_URETER_EXALLC for full statistics.
Malignant neoplasm of ureter
C3_URETER
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
83 |
4. Check minimum number of eventsNone |
83 |
5. Include endpointsNone |
83 |
6. Filter based on genotype QC (FinnGen only) |
83 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of ureter
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 83 | 28 | 55 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.02 |
| Median age at first event (years) | 73.85 | 73.22 | 74.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 74
- Matched controls
- 738
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C66
ICD-10 Finland
Malignant neoplasm of ureter
4518.8
82.4
64
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
80.6
62
*
UKC02
NOMESCO Finland
Cystoscopy
54.5
40.7
67
110
UKB02
NOMESCO Finland
Retrograde ureteroscopy
276.6
33.8
32
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
97.0
31.4
33
6
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
57.9
28.7
33
10
KAC20
NOMESCO Finland
Nephroureterectomy
370.0
26.5
25
*
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
370.0
26.5
25
*
R31
ICD-10 Finland
Unspecified haematuria
16.4
24.3
46
67
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
46.6
19.4
23
7
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
34.6
18.8
24
10
KCD02
NOMESCO Finland
Transurethral resection of bladder
25.9
18.7
26
15
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
100.3
15.2
16
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
35.8
15.2
19
7
TPH07
NOMESCO Finland
Cathetrisation of artery
9.5
12.4
27
42
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
11.5
10.6
20
23
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
24.2
10.3
14
7
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
10.5
10.2
20
25
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
114.0
9.7
10
*
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
114.0
9.7
10
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.9
9.4
17
18
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
8.5
8
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
+∞
8.5
8
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
25.4
8.3
11
5
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
25.4
8.3
11
5
KH1AD
NOMESCO Finland
CT of urinary organs
17.6
8.0
12
8
130
Kela drug reimbursment
Malignant tumour
6.6
7.9
21
42
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
50.5
7.9
9
*
KBH20
NOMESCO Finland
Replantation of ureter
+∞
7.4
7
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
11.0
7.1
13
14
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
7.1
31
107
WX402
NOMESCO Finland
General anaesthesia
5.6
7.0
21
49
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.8
6.8
24
67
B01AB05
ATC
enoxaparin; parenteral
3.8
6.7
36
147
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.4
6.1
23
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
56
255
4.68
10.43
7.4
3.3
—
—
—
0
0
53
272
3.62
7.47
6.6
3.7
—
—
—
0
0
43
199
3.41
7.05
7.7
3.3
0.3
0.3
e6/l
0.03
36
149
32
140
3.09
5.52
2.9
2.1
—
—
—
0
0
56
346
2.90
4.96
9.1
5.6
1.2
1.2
mmol/l
0.36
49
284
25
107
2.91
4.37
5.6
2.6
0.8
0.8
mmol/l
0.33
25
95
22
94
2.82
3.82
9.8
5.4
-2.1
1.3
mmol/l
2.13
16
79
25
117
2.63
3.64
8.0
3.1
0.8
1.5
e6/l
0.47
18
65
25
121
2.53
3.38
7.2
3.0
1.3
1.2
e6/l
0.06
17
69
52
354
2.26
3.14
10.2
5.5
9.4
11.8
umol/l
2.14
52
329
49
350
1.98
2.34
12.7
9.0
4.2
4.3
e9/l
0.11
39
301
70
573
2.42
2.27
28.7
17.4
48.7
28.4
mg/l
3.06
64
478
35
227
1.94
2.18
5.3
3.5
2.3
2.3
mmol/l
0.00
30
193
43
301
1.89
2.12
8.0
6.2
0.0
0.0
estimate
—
9
59
11
44
2.73
2.11
4.0
2.6
2.5
1.8
mmol/l
—
5
33
43
304
1.86
2.03
6.1
4.6
0.0
0.0
estimate
—
10
56
24
140
2.00
2.00
3.4
3.2
2.5
2.5
mmol/l
0.01
17
124
43
305
1.85
2.00
6.0
4.6
0.0
0.0
estimate
—
10
62
6
21
3.00
1.53
4.8
2.0
23.7
24.4
mmol/l
—
6
14
12
60
2.17
1.46
7.4
2.0
436.2
405.9
nmol/l
0.19
12
54
18
106
1.89
1.44
1.8
1.8
30.9
29.5
s
0.54
18
101
13
70
2.02
1.33
3.5
2.7
5.5
10.2
umol/l
1.19
13
61
32
230
1.64
1.30
7.4
5.0
—
—
—
0
0
25
170
1.67
1.24
6.2
2.9
34.6
32.1
u/l
0.16
25
157
9
47
2.02
1.06
7.8
3.5
0.2
0.1
e6/l
—
9
47
13
76
1.84
1.06
7.8
3.8
—
—
—
0
0
19
125
1.67
1.06
2.3
2.4
10.4
12.6
umol/l
0.62
19
107
62
549
1.51
0.84
33.2
17.0
53.4
71.7
ml/min/173m2
8.01
52
446
6
33
1.88
0.81
1.7
2.8
0.7
0.9
%
—
6
33
12
78
1.63
0.70
1.3
1.8
—
—
—
0
0
34
277
1.39
0.69
1.8
2.2
95.9
92.0
pmol/l
0.15
15
130
23
175
1.43
0.68
7.5
4.7
0.0
0.0
estimate
—
7
56
5
28
1.83
0.67
1.6
2.1
—
—
—
0
0
66
603
1.46
0.65
42.1
20.7
117.2
86.2
umol/l
3.23
66
603
0
20
0.00
0.61
0.0
1.5
—
31.8
—
0
15
0
20
0.00
0.61
0.0
1.2
—
—
—
0
0
0
22
0.00
0.60
0.0
1.7
—
—
—
0
0
0
23
0.00
0.59
0.0
1.9
—
—
—
0
0
9
59
1.59
0.57
2.0
1.3
—
—
—
0
0
15
110
1.44
0.53
2.5
2.6
2.1
2.3
g/l
0.46
15
98
7
48
1.50
0.48
6.3
4.6
23.3
24.4
mmol/l
—
7
48
5
35
1.46
0.40
5.6
2.7
17.8
121.5
u/ml
—
5
27
11
82
1.39
0.36
1.5
1.9
—
—
—
0
0
7
51
1.41
0.32
1.3
1.4
—
—
—
0
0
21
177
1.25
0.31
2.1
3.1
373.5
9848.6
umol/l
1.26
15
139
14
116
1.25
0.24
1.7
1.9
—
—
—
0
0
5
38
1.34
0.23
1.2
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.9
—
15.7
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
3.7
—
—
—
0
0
52
548
0.86
0.21
4.1
4.9
4.3
4.4
mmol/l
0.27
45
493
20
176
1.18
0.20
2.2
3.1
0.7
0.8
ug/l
0.21
13
124
28
254
1.15
0.19
2.1
2.3
83.8
76.1
nmol/l
0.40
22
216
52
546
0.87
0.19
4.1
4.9
1.3
1.4
mmol/l
0.55
45
482
54
564
0.88
0.17
4.8
5.5
2.4
2.5
mmol/l
0.61
48
501
6
76
0.77
0.16
11.7
10.5
—
—
—
0
0
54
517
1.13
0.15
5.8
4.9
1.9
2.0
mu/l
0.32
49
448
24
262
0.88
0.15
1.9
2.3
—
—
—
0
0
5
48
1.04
0.09
1.0
1.2
—
—
—
0
0
20
187
1.09
0.07
1.5
2.1
334.1
294.5
u/l
0.06
20
179
25
238
1.07
0.06
3.3
4.5
19.2
21.5
%
0.42
13
125
52
531
0.94
0.04
3.7
4.3
1.3
1.2
mmol/l
0.89
45
466
14
131
1.08
0.04
1.5
1.7
1.8
1.5
mg/l
—
9
98
56
551
1.05
0.03
5.5
5.4
6.1
6.2
mmol/l
0.21
49
491
53
538
0.96
0.02
7.4
6.6
41.8
41.6
mmol/mol
0.07
48
492
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
5.3
—
210.6
—
0
7
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
104.4
—
0
7
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
2.7
—
23.2
—
0
9
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
0
8
0.00
0.00
0.0
4.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_URETER – Malignant neoplasm of ureter
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).